Carsten Spanka

This inventor holds 10 USPTO granted patents and 8 published patent applications, plus 1 CIPO patent and 5 EPO patents. Top assignees: Novartis Ag, Irm LLC, Euroscreen S.a.. Active years: 2009-2025.

USPTO Granted Patents = 10 (Patent Applications = 8)

% Patents Active = 60.0

CIPO Patents = 1

EPO Patents = 5 (Patent Applications = 2)

Average Co-Inventor Count = 4.6

ph-index = 2

Forward Citations = 80(Granted Patents)

Location History:

Rheinfelden, DE (2009)
Loerrach, DE (2013)
Basel, CH (2014)
Lorrach, DE (2013 - 2018)
Lörrach, DE (2009 - 2024)

Company Filing History:

Scripps Research Institute

patents

where one patent can have more than one assignee

Years Active: 2009-2025

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12404261 - Compounds and compositions for treating conditions associated with cGAS (2025-09-02),

2. 11932630 - Heteroaryl aminopropanol derivatives (2024-03-19),

3. 10138232 - Naphthyridinedione derivatives (2018-11-27),

4. 9884862 - Pyridopyrimidinedione derivatives (2018-02-06),

5. 9649314 - Pyrimido[4,5-b]quinoline-4,5(3H,10H)-diones (2017-05-16),

6. 8822468 - 3-Methyl-imidazo[1,2-b]pyridazine derivatives (2014-09-02),

7. 8552002 - Compounds and compositions as protein kinase inhibitors (2013-10-08),

8. 8497075 - Methods of identifying a modulator that inhibits the binding between Epstein-Barr virus induced receptor 2 and cholesterol derived ligands (2013-07-30),

9. 7625950 - Amino-propanol derivatives as sphingosine-1-phosphate receptor modulator (2009-12-01),

10. 7612238 - Amino-propanol derivatives (2009-11-03),

Title: Biography of Inventor Carsten Spanka

Introduction: Carsten Spanka is a notable inventor based in Lorrach, Germany. He has made significant contributions to the field of medicinal chemistry, holding a total of 9 patents. His work primarily focuses on developing compounds and compositions for treating various medical conditions.

Latest Patents: Among his latest patents are "Compounds and compositions for treating conditions associated with cGAS," which relates to a compound of Formula (I) or its pharmaceutically acceptable variants. Another significant patent is for "Naphthyridinedione derivatives," which details a compound of the formula (I') and its applications as a medicament.

Career Highlights: Carsten has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Irm LLC. His experience in these organizations has allowed him to refine his expertise in drug development and innovation.

Collaborations: Throughout his career, Carsten has collaborated with esteemed colleagues such as Niko Schmiedeberg and Pascal Furet. These partnerships have contributed to the advancement of his research and the successful development of his inventions.

Conclusion: Carsten Spanka's innovative work and dedication to medicinal chemistry have established him as a respected inventor in his field. His contributions continue to impact the development of new treatments and therapies.